Affiliation:
1. M.D Psychiatry, Senior Resident at Institute of Mental Health And Neuroscience Kashmir.
Abstract
BACKGROUND- our study was aimed to know does Naltrexone used in opioid-dependent patient has any relation with
the onset of depression. METHOD- Naltrexone was given to 30 opioid-dependent patients who had undergone inpatient
detoxication with no underlying psychiatric comorbidity at baseline. HAM-D was applied at 2,4,6 weeks post Naltrexone initiation. RESULTS:
Our study showed that at 2 weeks, 60% of patients showed depressive symptoms out of which 37% met the criteria for mild depressive disorder
and 23% met the criteria for moderate to severe depression. At 4 and 6 weeks, majority continued to be depressive while only 3% of the patients
showed improvement in depressive features. CONCLUSION: From our study, we concluded that a positive correlation was found between
Naltrexone and Depression in Opioid users
Reference7 articles.
1. O’Brien CP, Greenstein R, Woody GE. Update on naltrexone treatment. In: Peterson RC, ed. The international challenge of drug abuse: NIDA research monograph series. Rockville, Maryland: Department of Health, Education, and Welfare, 1978: 315–320.
2. Darke S, Ross J. Polydrug dependence and psychiatric comorbidity among heroin injectors. Drug and Alcohol Dependence 1997; 48:135–141.
3. Hamilton M. A rating scale for depression J Neurol, Neurosurg Psychiatry 1960; 23: 56–62.
4. David J. Mysels , M.D., M.B.A., Wendy Y. Cheng , M.P.H., Edward V. Nunes , M.D. &Maria A. Sullivan , M.D., Ph.DThe association between naltrexone treatment and symptoms of depression in opioid-dependent patients;Pages 22-26 | Published online: 30 Dec 2010.
5. Catherine Spooner and Kate Hetherington;SOCIAL DETERMINANTS OF DRUG USE;NATIONAL DRUG AND ALCOHOL RESEARCH CENTRE, UNIVERSITY OF NEW SOUTH WALES, SYDNEY, 2004:ISBN: 0 7334 2244 6